top of page

Conitec Submissions for the Brazilian Public Health System

We structure and conduct comprehensive submission dossiers in accordance with the Brazilian Ministry of Health's Methodological Guidelines — from evidence strategy planning to technical support throughout the public consultation process.

The process of incorporating technologies into the SUS (Brazilian Public Health System)

Technical analysis

Evidence assessment, models and impact

Public consultation

Contributions from society and the sector

BANNERS ARTICLES LINKEDIN HTA (7).png

Submission via e-GITS

Electronic protocol and document verification

Preliminary deliberation

Initial recommendation from Conitec

Final decision

Recommendation and decision of the ministry

180

days

legal deadline

(renewable +90 days)

How HTAnalyze supports your submission

Access strategy

Clinical and economic positioning;

Relevant comparators in the SUS;

Technical and regulatory risks.

 

Before any submission, we map the competitive landscape: what technologies are already incorporated into the SUS (Brazilian Public Health System), how your product differentiates itself clinically and economically, and what regulatory obstacles may arise throughout the process.

 

This analysis guides the entire dossier's construction, avoiding rework and strengthening the technical defense points from the outset.

Economic Evaluation

Cost-effectiveness, utility, and minimization models;

Budget impact analysis.

 

We build tailored economic models for the clinical landscape of technology, decision trees for targeted interventions, Markov models for chronic conditions, and partitioned survival models for oncology.

 

The results are accompanied by deterministic and probabilistic sensitivity analyses, while the budgetary impact projects market share and technological diffusion over 5 years, based on real Brazilian epidemiology.

Clinical evidence

Systematic review and meta-analysis;
Comparative critical synthesis;
Rational Clinical Narrative.

 

We gathered and critically evaluated all available scientific literature on the technology and its comparators, identifying gaps, biases, and the robustness of the evidence.

 

The result is a structured clinical narrative, clear enough for lay members of the committee, yet rigorous enough to withstand technical questioning.

Dossier Development & Strategic Support

Complete preparation of the Conitec dossier;

Strategic support after submission.

 

We drafted the Main Document in its entirety, strictly following the template required by Conitec, from the technical description of the technology to the bibliographic references.

 

After submission, we continue to work alongside you: preparing responses to committee questions, analyzing contributions from the public consultation, and adjusting the dossier as needed until the final decision.

HTANALYZE DIFFERENTIALS

 

Direct experience with submissions in Brazil.

Expertise in health economics and market access.

Team with PhDs and experience in ATS.

Full alignment with Brazilian methodological requirements.

Our expertise covers every critical dimension of the submission process.

Market Access Strategy

  • Definition of the clinical and economic positioning

  • Analysis of relevant comparators within the Brazilian Public Health System (SUS)

  • Assessment of technical and regulatory risks

Clinical Evidence

  • Systematic reviews and meta-analyses

  • Comparative critical evidence synthesis

  • Development of the Rational Clinical Narrative

Economic Evaluation

  • Cost-effectiveness, cost-utility, and cost-minimization models

  • Decision-tree models for therapeutic interventions and diagnostic tests

  • Markov models

  • Partitioned survival models

  • Other tailored modeling approaches

Results presented as:

  • ICER / ICUR

  • CEAC (Cost-Effectiveness Acceptability Curve)

  • Deterministic and probabilistic sensitivity analyses

Budget Impact Analysis

Comprehensive modeling considering:

  • Brazilian epidemiology or demand-based target population estimates

  • Expected market share

  • Technology diffusion and uptake

  • Five-year time horizon

  • Full alignment with Brazilian methodological guidelines and HTA requirements

HtAnalyze

International presence. Distributed structure.

Brazil:

Porto Alegre • Florianópolis • Santo André

 

United States:

Lewes – Delaware

 

Europe:

Glasgow – Scotland

E-mail

Telephones

+55 51 3013 1341

+55 51 99547 5196 (Whatsapp)

Connect

  • Facebook
  • LinkedIn
  • Instagram

© 2026 HTAnalyze Consultoria e Treinamento LTDA and HTAnalyze Global LLC

bottom of page